Central Virginia

Filter by Region, Sector, or Focus
The UVA Manning Institute of Biotechnology positions UVA at the very forefront of cutting-edge medicine, such as cellular and gene therapies that revolutionize how diseases are treated and cured.
Explore 2022's first quarter edition of the Virginia Economic Review featuring a story on UVA and its support for the life sciences industry in Charlottesville (p. 32).

A new cross-curricular specialized course of study in the M.S. in Commerce Program will offer students indispensable knowledge and learning experiences while facilitating valuable industry and alumni engagement.

Discover the University's contributions to Virginia through a series of compelling, vignette-style highlights presented in this first edition report. Understand UVA as an engine for inclusive economic growth by exploring the initiatives that…
Discover the University's contributions to Virginia through a series of compelling, vignette-style highlights presented in this first edition report. Understand UVA as an engine for inclusive economic growth by exploring the initiatives that…
Central Virginia nonprofits can apply for grants to support community health initiatives through a partnership between the Charlottesville Area Community Foundation and the University of Virginia Health System.
Local biotechnology industry leader Nikki Hastings, PhD, has been named the first Executive Director of the CvilleBioHub, a non-profit that connects and supports the Charlottesville-area biotechnology sector.  CvilleBioHub will receive strategic pla
The UVA Licensing & Ventures Group helps discoveries reach their full potential in the marketplace. In 2018 there were 213 invention disclosures filed, 59 U.S. patents issued and 77 transactions with commercial partners. 
UVA Professor Shawn Russell helps those with disabilities take on skiing, proving that biomechanics research has real-life applications that can change lives for the better in Virginia and beyond.
Insulin delivery technology developed at UVA and commercialized by TypeZero Technologies, Inc. received initial support from UVA's Licensing and Ventures Group (LVG).
The UVA Licensing & Ventures Group (LVG) has invested in three Charlottesville-based ventures that grew out of University research. TypeZero Technologies Inc., TearSolutions Inc., and Mission Secure Inc.